ISO 26825-2020 PDF

Full title and description

ISO 26825:2020 — Anaesthetic and respiratory equipment — User-applied labels for syringes containing drugs used during anaesthesia — Colours, design and performance. This International Standard specifies design, colour and performance requirements for user-applied syringe labels so that the contents can be reliably identified immediately before use during anaesthesia.

Abstract

Gives requirements for labels attached to syringes used in anaesthesia: colour coding for core drug groups, label size and layout, typographical characteristics (drug name prominence and concentration presentation), and general performance (adhesion, durability, legibility). The standard notes that national/regional regulations may require additional labelling (for example bar coding) but does not specify those additional requirements.

General information

• Status: Published (Edition 2, under systematic review as an International Standard).
• Publication date: October 2020 (ISO edition 2, 2020-10).
• Publisher: International Organization for Standardization (ISO).
• ICS / categories: 11.040.10, 11.040.25 (anaesthetic, respiratory equipment; syringes/needles/catheters).
• Edition / version: Edition 2 — 2020.
• Number of pages: 9 pages (ISO published document length).

Key bibliographic and lifecycle details above are taken from the ISO catalogue entry for ISO 26825:2020.

Scope

ISO 26825:2020 applies to user-applied labels for syringes containing drugs used during anaesthesia and defines the colours, design, dimensions, typographical requirements and minimum performance characteristics of those labels so the syringe contents can be identified immediately before use. It does not specify labels applied by the drug manufacturer and does not replace any national or regulatory labelling requirements (e.g., bar codes). The standard focuses on a set of core drug groups commonly used in anaesthesia.

Key topics and requirements

• Colour coding for core anaesthetic drug groups to aid rapid visual identification (standardised palette for groups such as induction agents, opioids, local anaesthetics, muscle relaxants, sympathomimetics, etc.).
• Label design and layout: recommended label dimensions, placement of drug name and concentration, and contrast/legibility requirements so information remains readable in clinical use.
• Typographic characteristics: prominence of generic drug name and concentration, minimum font sizes, letter spacing and use of upper/lower case to minimise misreading.
• Performance: requirements for adhesion, resistance to fluids and handling, and durability of printed information during normal anaesthetic procedures.
• Operational note: labels are intended as an aid only — users must always read the label and confirm the drug prior to administration.
• Non-coverage: the standard does not mandate or specify bar-coding or other machine-readable formats (national/regional regulations may require these as additional measures).

The above technical topics and limitations are described in the ISO abstract and scope.

Typical use and users

Primary users and stakeholders include anaesthetists, perioperative and critical-care nurses, hospital pharmacy services, manufacturers of pre-printed or user-applied syringe labels, and healthcare safety/quality teams implementing medication-safety systems in operating theatres, emergency and intensive-care settings. Clinical guidance and local policy groups commonly reference ISO 26825 when defining hospital syringe-labelling practice.

Related standards

ISO 26825:2020 supersedes ISO 26825:2008. Regional/adopted equivalents and related publications include identically adopted versions (for example BS EN ISO 26825:2022 and other national adoptions) and guidance from professional bodies on syringe labelling and medication safety; clinicians should check national regulations and professional guidance for any additional or mandatory requirements.

Keywords

syringe labels, anaesthesia, colour coding, drug groups, labelling design, label performance, medication safety, ISO 26825, user-applied labels.

FAQ

Q: What is this standard?

A: ISO 26825:2020 is an International Standard that specifies the colours, design and performance requirements for user-applied labels for syringes used during anaesthesia so syringe contents can be identified immediately before use.

Q: What does it cover?

A: It covers label colour coding for core drug groups, label size and layout, typographic requirements (how drug name and concentration should be presented), and basic performance requirements (adhesion, legibility, resistance to fluids and handling). It does not cover manufacturer-applied syringe/cartridge labels or replace any regional regulatory labelling requirements (e.g., bar codes).

Q: Who typically uses it?

A: Clinicians (anaesthetists, perioperative nurses, ICU teams), hospital pharmacy departments, label manufacturers, and patient-safety personnel use the standard as a reference when implementing syringe-labelling practice and producing compliant labels. Professional societies and national guidance often reference ISO 26825 when updating local policies.

Q: Is it current or superseded?

A: ISO 26825:2020 (Edition 2) is the current published edition and replaces the withdrawn ISO 26825:2008. The ISO catalogue entry lists the 2020 edition as published (2020-10) and notes the earlier edition as withdrawn.

Q: Is it part of a series?

A: It is a stand-alone ISO standard focused on syringe labelling within the anaesthetic/respiratory equipment area (technical committee ISO/TC 121/SC 1). It is associated by topic with other medical-device and labelling standards and with national/regional adoptions (EN/BS adoptions), but it is not a multi‑part ISO series.

Q: What are the key keywords?

A: Syringe labels, colour coding, anaesthesia drugs, user-applied labels, label design, labelling performance, medication safety, ISO 26825.